Belén Garijo, CEO of Merck KGaA, weighs in on Europe's competitiveness and the pharma giant's preparations for the impact of ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and ...

The Red Bluff Bull and Gelding Sale started on Tuesday with the sifting and grading of all range-ready calving ease and bulls ...